FDA Inspection
N-Molecular, Inc. dba SOFIEN-Molecular, Inc. dba SOFIE – FDA Inspection, Jan 13, 2020
Record Details
This FDA Inspection record concerns N-Molecular, Inc. dba SOFIE, with an inspection on January 13, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- N-Molecular, Inc. dba SOFIE
- Inspection Date
- January 13, 2020
- Product Type
- Drugs
View Company Profile
ID · 0e5bd43a-8283-4d63-bbf8-6a0e2f429d73
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1115024
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 212.71(c)Correction of problems
- 21 CFR 212.10Personnel not qualified
- 21 CFR 212.70(b)Compendial test procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of N-Molecular, Inc. dba SOFIE
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | New York District Office | |
| February 12, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 14, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for N-Molecular, Inc. dba SOFIE
- FDA Inspection 1290166 - 2026-02-05
- FDA Inspection 913744 - 2015-02-12
- FDA Inspection 754503 - 2011-11-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.